Hirshberg, B., & Raz, I. (2011). Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs. American Diabetes Association.
シカゴスタイル引用形Hirshberg, Boaz, , Itamar Raz. Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements On the Development of Novel Antidiabetes Drugs. American Diabetes Association, 2011.
MLA引用形式Hirshberg, Boaz, , Itamar Raz. Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements On the Development of Novel Antidiabetes Drugs. American Diabetes Association, 2011.
警告: この引用は必ずしも正確ではありません.